Skip to main content
Clinical Trials/RBR-5tzcnw
RBR-5tzcnw
Completed
Phase 4

Influence of the depression treatment with escitalopram in mild to moderate arterial hypertension

Marcello Finardi Peixoto0 sitesNovember 5, 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
essential (primary) hypertension
Sponsor
Marcello Finardi Peixoto
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Marcello Finardi Peixoto

Eligibility Criteria

Inclusion Criteria

  • 18 to 65 years; arterial hypertension stage 1 or 2; major depressive disorder

Exclusion Criteria

  • Liver insuficiency; cardiac insuficiency, renal insuficiency; secundary arterial hypertension; use of psycotropics; psychotic disorder; alcohol or substances disorder; suicide risk

Outcomes

Primary Outcomes

Not specified

Similar Trials